Monitoring in practice – How are UK academic clinical trials monitored? A survey

por Love, Sharon B., Yorke-Edwards, Victoria, Lensen, Sarah, Sydes, Matthew R.
Publicado 2020

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation The...

por Dutton, Susan J, Kenealy, Nicola, Love, Sharon B, Wasan, Harpreet S, Sharma, Ricky A
Publicado 2014

Protecting blinded trials in electronic hospital systems

por Sydes, Matthew R, Wong, Wai Keong, Bakhai, Ameet, Joffe, Nicola, Love, Sharon B
Publicado 2022

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials

por Noor, Nurulamin M, Love, Sharon B, Isaacs, Talia, Kaplan, Richard, Parmar, Mahesh K B, Sydes, Matthew R
Publicado 2022

Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers

por Hsieh, Shao-Fan, Yorke-Edwards, Victoria, Murray, Macey L, Diaz-Montana, Carlos, Love, Sharon B, Sydes, Matthew R
Publicado 2023

Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy on...

por van Werkhoven, Erik, Hinsley, Samantha, Frangou, Eleni, Holmes, Jane, de Haan, Rosemarie, Hawkins, Maria, Brown, Sarah, Love, Sharon B
Publicado 2020

Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data

por Love, Sharon B., Kilanowski, Anna, Yorke-Edwards, Victoria, Old, Oliver, Barr, Hugh, Stokes, Clive, Kendall, Catherine, Sydes, Matthew R.
Publicado 2021

Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic

por Love, Sharon B., Armstrong, Emma, Bayliss, Carrie, Boulter, Melanie, Fox, Lisa, Grumett, Joanne, Rafferty, Patricia, Temesi, Barbara, Wills, Krista, Corkhill, Andrea
Publicado 2021

Making a distinction between data cleaning and central monitoring in clinical trials

por Love, Sharon B, Yorke-Edwards, Victoria, Diaz-Montana, Carlos, Murray, Macey L, Masters, Lindsey, Gabriel, Michelle, Joffe, Nicola, Sydes, Matthew R
Publicado 2021

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment...

por Virdee, Pradeep S, Moschandreas, Joanna, Gebski, Val, Love, Sharon B, Francis, E Anne, Wasan, Harpreet S, van Hazel, Guy, Gibbs, Peter, Sharma, Ricky A
Publicado 2017

Data provenance and integrity of health-care systems data for clinical trials

por Murray, Macey L, Love, Sharon B, Carpenter, James R, Hartley, Suzanne, Landray, Martin J, Mafham, Marion, Parmar, Mahesh K B, Pinches, Heather, Sydes, Matthew R
Publicado 2022

Accessing routinely collected health data to improve clinical trials: recent experience of access

por Macnair, Archie, Love, Sharon B., Murray, Macey L., Gilbert, Duncan C., Parmar, Mahesh K. B., Denwood, Tom, Carpenter, James, Sydes, Matthew R., Langley, Ruth E., Cafferty, Fay H.
Publicado 2021

Access to routinely collected health data for clinical trials – review of successful data requests to UK registries

por Lensen, Sarah, Macnair, Archie, Love, Sharon B., Yorke-Edwards, Victoria, Noor, Nurulamin M., Martyn, Meredith, Blenkinsop, Alexandra, Diaz-Montana, Carlos, Powell, Graham, Williamson, Elizabeth, Carpenter, James, Sydes, Matthew R.
Publicado 2020

What is the purpose of clinical trial monitoring?

por Love, Sharon B., Yorke-Edwards, Victoria, Ward, Elizabeth, Haydock, Rebecca, Keen, Katie, Biggs, Katie, Gopalakrishnan, Gosala, Marsh, Lucy, O’Sullivan, Lydia, Fox, Lisa, Payerne, Estelle, Hood, Kerenza, Meakin, Garry
Publicado 2022

Embracing model-based designs for dose-finding trials

por Love, Sharon B, Brown, Sarah, Weir, Christopher J, Harbron, Chris, Yap, Christina, Gaschler-Markefski, Birgit, Matcham, James, Caffrey, Louise, McKevitt, Christopher, Clive, Sally, Craddock, Charlie, Spicer, James, Cornelius, Victoria
Publicado 2017

How to design a dose-finding study using the continual reassessment method

por Wheeler, Graham M., Mander, Adrian P., Bedding, Alun, Brock, Kristian, Cornelius, Victoria, Grieve, Andrew P., Jaki, Thomas, Love, Sharon B., Odondi, Lang’o, Weir, Christopher J., Yap, Christina, Bond, Simon J.
Publicado 2019

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial

por Masurekar, Ashish Narayan, Parker, Catriona A., Shanyinde, Milensu, Moorman, Anthony V., Hancock, Jeremy P., Sutton, Rosemary, Ancliff, Philip J., Morgan, Mary, Goulden, Nicholas J., Fraser, Chris, Hoogerbrugge, Peter M., Revesz, Tamas, Darbyshire, Philip J., Krishnan, Shekhar, Love, Sharon B., Saha, Vaskar
Publicado 2014

MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer

por Walker, Alexandra K., Karaszi, Katalin, Valentine, Helen, Strauss, Victoria Y., Choudhury, Ananya, McGill, Shaun, Wen, Kaisheng, Brown, Michael D., Ramani, Vijay, Bhattarai, Selina, Teo, Mark T.W., Yang, Lingjian, Myers, Kevin A., Deshmukh, Nayneeta, Denley, Helen, Browning, Lisa, Love, Sharon B., Iyer, Gopa, Clarke, Noel W., Hall, Emma, Huddart, Robert, James, Nicholas D., Hoskin, Peter J., West, Catharine M.L., Kiltie, Anne E.
Publicado 2019

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

por Femminella, Grazia Daniela, Frangou, Eleni, Love, Sharon B., Busza, Gail, Holmes, Clive, Ritchie, Craig, Lawrence, Robert, McFarlane, Brady, Tadros, George, Ridha, Basil H., Bannister, Carol, Walker, Zuzana, Archer, Hilary, Coulthard, Elizabeth, Underwood, Ben R., Prasanna, Aparna, Koranteng, Paul, Karim, Salman, Junaid, Kehinde, McGuinness, Bernadette, Nilforooshan, Ramin, Macharouthu, Ajay, Donaldson, Andrew, Thacker, Simon, Russell, Gregor, Malik, Naghma, Mate, Vandana, Knight, Lucy, Kshemendran, Sajeev, Harrison, John, Brooks, David J., Passmore, Anthony Peter, Ballard, Clive, Edison, Paul
Publicado 2019

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

por Femminella, Grazia Daniela, Frangou, Eleni, Love, Sharon B., Busza, Gail, Holmes, Clive, Ritchie, Craig, Lawrence, Robert, McFarlane, Brady, Tadros, George, Ridha, Basil H., Bannister, Carol, Walker, Zuzana, Archer, Hilary, Coulthard, Elizabeth, Underwood, Ben R., Prasanna, Aparna, Koranteng, Paul, Karim, Salman, Junaid, Kehinde, McGuinness, Bernadette, Nilforooshan, Ramin, Macharouthu, Ajay, Donaldson, Andrew, Thacker, Simon, Russell, Gregor, Malik, Naghma, Mate, Vandana, Knight, Lucy, Kshemendran, Sajeev, Harrison, John, Hölscher, Christian, Brooks, David J., Passmore, Anthony Peter, Ballard, Clive, Edison, Paul
Publicado 2020